3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
Cisplatin
13
Radiotherapy, Intensity-Modulated
11
Radiotherapy
5
Carboplatin
5
Radiation
4
Cetuximab
4
durvalumab
3
Platinum
3
Nivolumab
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Specimen Handling
2
Restraint, Physical
2
Paclitaxel
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Bupropion
2
Biopsy
2
Acupuncture Therapy
2
veliparib
1
utomilumab
1
sodium thiosulfate
1
ficlatuzumab
1
dehydroftorafur
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oropharyngeal Neoplasms
×
entinostat
×
Clear all
No trials found.